Cargando…
Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies
Although gene transfer to hematopoietic stem cells (HSCs) has shown therapeutic efficacy in recent trials for several individuals with inherited disorders, transduction incompleteness of the HSC population remains a hurdle to yield a cure for all patients with reasonably low integrated vector number...
Autores principales: | Bhukhai, Kanit, de Dreuzy, Edouard, Giorgi, Marie, Colomb, Charlotte, Negre, Olivier, Denaro, Maria, Gillet-Legrand, Béatrix, Cheuzeville, Joëlle, Paulard, Anaïs, Trebeden-Negre, Hélène, Borwornpinyo, Suparerk, Sii-Felice, Karine, Maouche, Leila, Down, Julian D., Leboulch, Phillippe, Payen, Emmanuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835017/ https://www.ncbi.nlm.nih.gov/pubmed/29221807 http://dx.doi.org/10.1016/j.ymthe.2017.10.015 |
Ejemplares similares
-
Current and future alternative therapies for beta-thalassemia major
por: de Dreuzy, Edouard, et al.
Publicado: (2016) -
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene
por: Negre, Olivier, et al.
Publicado: (2016) -
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
por: Negre, Olivier, et al.
Publicado: (2015) -
The Bioactive Peptide SL-13R Expands Human Umbilical Cord Blood Hematopoietic Stem and Progenitor Cells In Vitro
por: Nii, Takenobu, et al.
Publicado: (2021) -
High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing
por: Ling, Chen, et al.
Publicado: (2016)